Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02966145 · ClinicalTrials.gov registry record
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
A clinical trial of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome(CBS), sponsored by University of California, San Francisco.
- Completed
- Registry status
- 293
- Enrollment target
- 8
- Study locations
NCT02966145: Completed study of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome(CBS), sponsored by University of California, San Francisco.
NCT02966145 is a study of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome(CBS) that has completed, run by University of California, San Francisco. The registered enrollment target is 293 participants, below the 640-participant average among 5 other Progressive Supranuclear Palsy (PSP) trials with a reported enrollment target (54% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02966145, a study of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome(CBS), has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 293 participants
- Enrollment target
- 8
- Study locations
Study Summary
The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used in the future to calculate statistical power for clinical drug trials. The study will also provide information about the relative value of novel imaging techniques for diagnosis, as well as the value of imaging techniques versus testing of blood, urine, and cerebrospinal fluid (CSF) 'biomarkers'.
Primary Outcome
Change from Baseline of Tau protein distribution in the brain.
Conditions Studied
Interventions
- OTHER Observational Study
Study Locations (8)
California
- University of California, San Diego (UCSD) - San Diego
- University of California, San Francisco (UCSF) - San Francisco
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Harvard University - Massachusetts General Hospital - Charlestown
Minnesota
- Mayo Clinic - Rochester - Rochester
New York
- Columbia University - New York
Pennsylvania
- University of Pennsylvania - Philadelphia
Ontario
- University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2016-01 |
| Est. Completion | 2024-02-28 |
What the finished NCT02966145 record still lists
NCT02966145 is an observational study that tracks outcomes without assigning an intervention. The registered 293 participants enrollment target is mid-sized for trials with a published cap, below the 640-participant average among 5 other Progressive Supranuclear Palsy (PSP) trials with a reported enrollment target (54% lower).
The record links to 6 conditions, with Progressive Supranuclear Palsy (PSP) appearing as the primary indexed condition, and to 1 intervention - of which Observational Study is the first listed.
NCT02966145 lists 8 locations in 7 states (California, Maryland, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT02966145 about?
NCT02966145 is a clinical study titled "4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2". The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used in the future to calculate statistical power for clinical drug trials. The study will also provide information about the relative value of ...
What is the current status of trial NCT02966145?
This trial is currently completed. The enrollment target is 293 participants. The study started on 2016-01. Estimated completion is 2024-02-28.
What conditions does trial NCT02966145 study?
This clinical trial studies the following conditions: Progressive Supranuclear Palsy (PSP), Corticobasal Syndrome(CBS), Corticobasal Degeneration (CBD), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), Cortical-basal Ganglionic Degeneration (CBGD).
What interventions are being tested in trial NCT02966145?
The interventions under investigation include: Observational Study (OTHER).
Who is sponsoring clinical trial NCT02966145?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02966145 being conducted?
This trial has 8 study locations across California, Maryland, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Progressive Supranuclear Palsy (PSP)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain
RECRUITING · Early Phase 1
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RECRUITING
-
UPenn Observational Research Repository on Neurodegenerative Disease
RECRUITING
-
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy
COMPLETED · Phase 1
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia